British American Tobacco p.l.c.
No SEC Form 4 filings for $BTI in the last 30 days.
British American Tobacco (BTI) plans to cut about 5,500 international jobs and move around 3,500 roles to partners as part of its Fit2Win restructuring. The company targets about £600 million ($792 million) in annual savings by 2028, citing AI adoption and cost streamlining. BTI said U.S. roles are insulated.
Philip Morris International (PM) opened a $1.2B, 780,000 sq ft Aurora, Colorado campus to produce ZYN nicotine pouches, after about 19 months. The FDA authorized 20 ZYN products as modified risk tobacco products on June 30. Reuters also cited PM beating Q2 estimates. The article notes Aurora cost rose from $600M and highlights BAT (BTI) growth and planned Velo Max rollout.
British American Tobacco (BTI) said its subsidiary B.A.T Capital Corporation, with guarantor entities, entered an underwriting agreement with a bank-led syndicate, incorporated into existing Form F-3 shelf registrations. It also executed Supplemental Indenture No. 26 and No. 27 with Citibank, N.A. as trustee, and received related legal opinions. No offering size or pricing was disclosed.
Over the past 7 days, alphai's AI scored 5 news stories mentioning BTI (British American Tobacco p.l.c.). Coverage has skewed bullish: 1 bullish, 4 neutral, and 0 bearish.
Recent BTI coverage spans earnings, corporate actions and financial news.
Restructuring and outsourcing tied to AI adoption should reinforce the cost-savings narrative, but it also signals execution risk and potential margin volatility if savings lag.
The piece frames BTI’s planned higher-strength pouch expansion as a direct competitive response to PM’s new ZYN capacity.
The filing confirms financing documentation execution but provides no deal size or pricing, limiting near-term earnings or liquidity read-through.
The deal is a capital-structure event that can affect BAT’s near-term funding costs and leverage optics, but it does not change operations or guidance in this text.
Guidance upgrade and capital allocation details (buyback, leverage target) can re-rate near-term earnings and balance-sheet risk for BTI.
alphai scores every news story that mentions BTI with an AI model for sentiment and relevance, and aggregates insider trades from British American Tobacco p.l.c.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
British American Tobacco (BTI) plans to cut about 5,500 international jobs and move around 3,500 roles to partners as part of its Fit2Win restructuring. The company targets about £600 million ($792 million) in annual savings by 2028, citing AI adoption and cost streamlining. BTI said U.S. roles are insulated.
4 min readPhilip Morris International (PM) opened a $1.2B, 780,000 sq ft Aurora, Colorado campus to produce ZYN nicotine pouches, after about 19 months. The FDA authorized 20 ZYN products as modified risk tobacco products on June 30. Reuters also cited PM beating Q2 estimates. The article notes Aurora cost rose from $600M and highlights BAT (BTI) growth and planned Velo Max rollout.
6 min readBritish American Tobacco (BTI) said its subsidiary B.A.T Capital Corporation, with guarantor entities, entered an underwriting agreement with a bank-led syndicate, incorporated into existing Form F-3 shelf registrations. It also executed Supplemental Indenture No. 26 and No. 27 with Citibank, N.A. as trustee, and received related legal opinions. No offering size or pricing was disclosed.
2 min readBritish American Tobacco (BAT) said its wholly owned subsidiary B.A.T. Capital Corporation priced a $1.5 billion notes offering. It includes $750 million 5.300% notes due 2033 and $750 million 5.550% notes due 2036, guaranteed by BAT and other entities including Reynolds American Inc. Expected to close 5 Aug 2026. Net proceeds for general corporate purposes, including potential debt repayment.
2 min readBritish American Tobacco (BTI) Q2 2026 earnings call reported 2.9% group revenue growth at constant currency and a 7.9% rise in adjusted diluted EPS. New Category revenue grew 18%, with Modern Oral up 66%. Smokeless was 19.8% of revenue. Full-year EPS guidance was upgraded to the mid of 5% to 8%, with GBP 1.3bn buyback for 2026 and Fit2Win savings of GBP 700m by 2028.
7 min readThursday, July 30, 2026 at 4:30 a.m. ET CALL PARTICIPANTS Chief Executive Officer - Tadeu Marroco Interim Chief Financial Officer - Javed Iqbal Group Head of Investor Relations - Victoria Buxton TAKEAWAYS Group Revenue -- 2.9% growth at constant currency, reflecting multi-category performance in the U.S. and an acceleration in New Category growth. Adjusted Diluted EPS -- 7.9% increase, supported by lower net finance costs following debt repayment and 4.4% growth from earning kickers.
7 min readKiwiSaver Investment in "Companies of Concern" Climbs to $11.1 Billion, even as Kiwis invest for positive outcomes at home New analysis of KiwiSaver portfolio holdings to March 2026 shows New Zealanders' retirement savings are increasingly split between rapidly growing investment in clean energy leaders and rising exposure to fossil fuel expansion, human rights violations, environmental harm and nuclear weapons production.
6 min readBrazil’s Attorney General is awaiting a ruling in Porto Alegre on a 2019 lawsuit seeking health cost recovery from cigarette makers. Submissions are complete, including a prosecutor opinion. Defendants include BAT Brasil (formerly Souza Cruz) and Philip Morris Brasil, plus parent firms British American Tobacco and Philip Morris International. The claim cites about 177,000 deaths and R$75 billion yearly healthcare costs.
3 min readBritish American Tobacco (BAT) raised its full-year adjusted EPS growth outlook to the middle of its 5% to 8% medium-term range, up from earlier guidance at the low end, citing strong US momentum and demand for its Velo nicotine pouches, offsetting weaker Asia. It kept revenue and adjusted operating profit growth at the low end of 3% to 5% and 4% to 6%. Six-month adjusted EPS was 164p, up 7.9% vs a 158.5p consensus.
4 min readBritish American Tobacco (BTI) reported lower first-half profit but higher revenue, citing higher adjustment items offsetting the profit decline. The company said it has confirmed its full-year guidance. The update matters for traders tracking earnings and outlook for BTI.
3 min read
